Healthcare AI startup Qritive has secured $7.5 million in a series A funding round led by MassMutual Ventures. Seeds Capital and Exfinity Venture Partners also participated in this round.
Qritive will use the funding to improve the product and expand it to other geographical locations. It will also support the company I regulatory clearances.
The company uses artificial intelligence to provide and accurate interpretations of pathology for improving health outcomes, cancer diagnosis, and enhancing imaging accuracy. Qritive’s solutions are approved by Singapore Health Sciences Authority (HSA) and are also CE certified.
“Complexity of diagnostics has increased considerably and having tools that increase accuracy and throughput really fast has become instrumental for clinicians worldwide,” said Aneesh Sathe, CEO of Qritive in a statement.
Qritive was founded in 2017 by Aneesh Sathe and Kaveh Taghipour. The company is based in Singapore and also has operations in the U.S. and India. It also raised $1.5 million in seed funding back in 2019 from SGinnovate and Pix Vine Capital.
